Performance Evaluation of the Elecsys GAAD Assay for the Detection of Hepatocellular Carcinoma Across Different Disease Stages and Etiologies

Home / Key Publications / Digital Algorithms / Performance Evaluation of the Elecsys GAAD Assay for the Detection of Hepatocellular Carcinoma Across Different Disease Stages and Etiologies

You May Also Like

Prof Chan Wah Keong

12 February 2026

LEAD Perspective: Evaluating GAAD – A Malaysian Multicentre Study

12 February 2026

LEAD Perspective: The Taiwan Liver Story – Hepatitis Elimination and HCC Surveillance

12 February 2026

LEAD Perspective: Asia Pacific Consensus Statement on the clinical and economic utility of biomarker-based algorithms in the early detection and surveillance of HCC

SHARE

Be the first to receive updates, event opportunities, and thought leadership insights.